Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax™
28. Dezember 2018 09:01 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today the submission of an application to the U.S. Food and Drug Administration (FDA) for...
Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries
12. April 2018 06:30 ET
|
Emergent Biosolutions, Inc.
GAITHERSBURG, Md., April 12, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market...